About Prolong Pharmaceuticals

Website
Website
Employees
Employees
11-50 employees View all
Industry
Industry
pharmaceuticals
Location
Location
300B Corporate Court,South Plainfield,New Jersey,US
Description
Information
Headquartered in South Plainfield, New Jersey, Prolong Pharmaceuticals, LLC is developing products to treat several diseases and their debilitating comorbidities which cause reduced quality of life, increased medical costs and significant mortality. Comorbidities are a common consequence of sickle cell disease, chemotherapy, atherosclerosis, diabetes and many other diseases. - The company's lead product, SANGUINATEā„¢, is focused on treating the comorbidities of sickle cell disease and hemorrhagic stroke - Prolong has a long-acting 3rd generation biologic in clinical development for the treatment of anemia, a comorbidity common with chronic kidney disease and cancer chemotherapy - Other products are also in development for comorbidities that result from diseases such as cardiovascular disorders and cancer ___________

Prolong Pharmaceuticals Alternatives

Industry
pharmaceuticals
Industry
pharmaceuticals
Industry
Pharmaceuticals
Industry
Pharmaceuticals

Frequently Asked Questions about Prolong Pharmaceuticals

What is Prolong Pharmaceuticals email format?

The widely used Prolong Pharmaceuticals email format is {f}{last} (e.g. [email protected]) with 60% adoption across the company.


What is Prolong Pharmaceuticals customer service number?

To contact Prolong Pharmaceuticals customer service number in your country click here to find.


Who is the CEO of Prolong Pharmaceuticals?

Abe Abuchowski is the CEO of Prolong Pharmaceuticals. To contact Abe Abuchowski email at [email protected] or [email protected].


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more